Benefits of SPRAVATO®
Patients choose SPRAVATO® because it provides unique benefits over other medications. For one, you’ll experience immediate symptom relief, as well as long-term benefits. A clinical trial showed that SPRAVATO® patients experienced improvements at the four-week mark compared to the placebo group. Another significant benefit is that esketamine is safer than ketamine for depression treatment. Esketamine is a more potent ketamine variant that doctors can administer in smaller doses for positive results.
SPRAVATO® might result in a few side effects during and after treatment. Patients may experience feelings of dissociation, or disconnection from their thoughts, feelings and experience. Other common symptoms include dizziness, increased blood pressure, nausea, feeling tired or drunk, numbness or low sensitivity, anxiety, sluggishness or elation.
You’ll receive SPRAVATO® treatment twice a week during your first month, once a week during the second month then once every week or two in the following months. Continue to take your other antidepressants according to your doctor’s recommendations during your treatment period.